tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Annabel Samimy, 177 are a BUY (81.19%), 41 are a HOLD (18.81%).
Analyst Annabel Samimy, currently employed at STIFEL, carries an average stock price target met ratio of 58.3% that have a potential upside of 47.02% achieved within 308 days.
Annabel Samimy’s has documented 368 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on APLS, Apellis Pharmaceuticals at 28-Feb-2025.
Analyst best performing recommendations are on VKTX (VIKING THERAPEUTICS).
The best stock recommendation documented was for EOLS (EVOLUS) at 1/28/2019. The price target of $27 was fulfilled within 10 days with a profit of $12.01 (80.12%) receiving and performance score of 80.12.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$13
3 years 3 months 16 days ago
(29-Aug-2022)
1/5 (20%)
$4.7 (56.63%)
176
Hold
3 years 3 months 21 days ago
(24-Aug-2022)
0/1 (0%)
$6.53 (25.64%)
Hold
$20
3 years 3 months 21 days ago
(24-Aug-2022)
0/4 (0%)
$14.21 (245.42%)
Buy
$15.25
$27
3 years 3 months 22 days ago
(23-Aug-2022)
7/11 (63.64%)
$0.09 (0.59%)
149
Hold
$14
3 years 3 months 22 days ago
(23-Aug-2022)
6/14 (42.86%)
$6.36 (83.25%)
228
What Year was the first public recommendation made by Annabel Samimy?
